🇺🇸 FDA
Patent

US 7402578

Methods for inhibiting cognitive deterioration in adults with down's syndrome

granted A61KA61K31/56A61K31/567

Quick answer

US patent 7402578 (Methods for inhibiting cognitive deterioration in adults with down's syndrome) held by Corcept Therapeutics Incorporated expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/56, A61K31/567, A61K31/573, A61K31/575